Approval · Notice of Compliance 3046 · 1998
RITALIN: Notice of Compliance 3046
Issued July 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3046
- Date
- July 27, 1998
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Central nervous system stimulant
Products in this notice
Medicinal ingredients
- METHYLPHENIDATE HYDROCHLORIDE 10 MG per TAB
- METHYLPHENIDATE HYDROCHLORIDE 20 MG per TAB